En
It
De
日本語
中文
Es
The fast-evolving biotech drug market is strongly influencing the demand for glass primary packaging.
For instance, as the intravenous administration of monoclonal antibodies in hospitals or clinics remains an expensive procedure that can generate inconvenience and discomfort for patients, several biopharma companies have started re-formulating their IV mAbs for large-volume, subcutaneous (SQ) delivery. This shift could enable the adoption of self-administration treatments using wearable injectors and hand-held devices.
Stevanato Group has developed large-volume glass cartridges (5mL up to 50mL) suited for the application of large volume biologics.
Large-volume cartridges can be supplied in bulk configuration or in EZ-fill® nest and tub, steam‑sterilized and ready-to-fill.
| Nest & Tub | ||
|---|---|---|
| 5 mL |
Pre-capped |
42 |
| 10 mL |
Pre-capped |
42 |
| 20 mL |
Pre-capped |
36 |
By collaborating with strategic partners, our cartridges are designed to be easily integrated into delivery devices.
They give device designers a wide choice of customization parameters, including the container length, diameter, volume, neck, and material choice for the stopper and plunger.
Reduced glass-to-glass contact during forming process to maximize mechanical resistance when paired with drug delivery systems
Optimized siliconization options depending on formats and device application
Pre-validated eco-systems of cartridges, rubber components, and delivery devices
Highly customizable, the dimensions can be tailored precisely upon request to fit your drug delivery device and application. At the same time, the collaboration with the leading device manufacturers already ensures pre-validated and standard cartridge systems.
Biologics
Sub-cutaneous drugs long delivery
Infusion Pumps for therapies for autoimmune diseases (e.g., Parkinson’s)